» Articles » PMID: 24133374

Phosphate Control in Dialysis

Overview
Publisher Dove Medical Press
Specialty Nephrology
Date 2013 Oct 18
PMID 24133374
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Prevention and correction of hyperphosphatemia is a major goal of chronic kidney disease-mineral and bone disorder (CKD-MBD) management, achievable through avoidance of a positive phosphate balance. To this aim, optimal dialysis removal, careful use of phosphate binders, and dietary phosphate control are needed to optimize the control of phosphate balance in well-nourished patients on a standard three-times-a-week hemodialysis schedule. Using a mixed diffusive-convective hemodialysis tecniques, and increasing the number and/or the duration of dialysis tecniques are all measures able to enhance phosphorus (P) mass removal through dialysis. However, dialytic removal does not equal the high P intake linked to the high dietary protein requirement of dialysis patients; hence, the use of intestinal P binders is mandatory to reduce P net intestinal absorption. Unfortunately, even a large dose of P binders is able to bind approximately 200-300 mg of P on a daily basis, so it is evident that their efficacy is limited in the case of an uncontrolled dietary P load. Hence, limitation of dietary P intake is needed to reach the goal of neutral phosphate balance in dialysis, coupled to an adequate protein intake. To this aim, patients should be informed and educated to avoid foods that are naturally rich in phosphate and also processed food with P-containing preservatives. In addition, patients should preferentially choose food with a low P-to-protein ratio. For example, patients could choose egg white or protein from a vegetable source. Finally, boiling should be the preferred cooking procedure, because it induces food demineralization, including phosphate loss. The integrated approach outlined in this article should be actively adapted as a therapeutic alliance by clinicians, dieticians, and patients for an effective control of phosphate balance in dialysis patients.

Citing Articles

Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications.

Siracusa C, Carabetta N, Morano M, Manica M, Strangio A, Sabatino J Int J Mol Sci. 2024; 25(23).

PMID: 39684805 PMC: 11642360. DOI: 10.3390/ijms252313096.


The effect of an educational video about healthy diet on metabolic control of patients on hemodialysis: an interventional study with a one-year follow-up.

Yasari F, Taherian M, Akbarian M, Vasheghani M BMC Nephrol. 2024; 25(1):262.

PMID: 39143571 PMC: 11323627. DOI: 10.1186/s12882-024-03693-w.


OSTEOPROTEGERIN AS AN EARLY SIGN OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER.

Grskovic A, Celic T, Spanjol J, Markic D, Devcic B, Bobinac D Acta Clin Croat. 2024; 62(Suppl2):46-52.

PMID: 38966016 PMC: 11221231. DOI: 10.20471/acc.2023.62.s2.7.


Management of serum phosphorus over a 1-year follow-up in patients on peritoneal dialysis prescribed sucroferric oxyhydroxide as part of routine care: a retrospective analysis.

Kalantar-Zadeh K, Ficociello L, Zhou M, Anger M BMC Nephrol. 2024; 25(1):197.

PMID: 38886636 PMC: 11184799. DOI: 10.1186/s12882-024-03633-8.


The relationship between dietary inflammatory index and osteoporosis among chronic kidney disease population.

Meng X, Sha W, Lou X, Chen J Sci Rep. 2023; 13(1):22867.

PMID: 38129528 PMC: 10739725. DOI: 10.1038/s41598-023-49824-5.


References
1.
Koleganova N, Piecha G, Ritz E, Schirmacher P, Muller A, Meyer H . Arterial calcification in patients with chronic kidney disease. Nephrol Dial Transplant. 2009; 24(8):2488-96. DOI: 10.1093/ndt/gfp137. View

2.
Moe S, Zidehsarai M, Chambers M, Jackman L, Radcliffe J, Trevino L . Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2010; 6(2):257-64. PMC: 3052214. DOI: 10.2215/CJN.05040610. View

3.
Maheshwari V, Samavedham L, Rangaiah G, Loy Y, Ling L, Sethi S . Comparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: a prospective randomized open-label clinical study protocol. BMC Nephrol. 2012; 13:156. PMC: 3561063. DOI: 10.1186/1471-2369-13-156. View

4.
Curran M, Robinson D . Lanthanum carbonate: a review of its use in lowering serum phosphate in patients with end-stage renal disease. Drugs. 2009; 69(16):2329-49. DOI: 10.2165/11202610-000000000-00000. View

5.
Botelho C, Rodrigues A, Oliveira J, Cabrita A . Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control. J Nephrol. 2012; 26(1):183-90. DOI: 10.5301/jn.5000109. View